<html>
<body>
  <header></header>
  <main>
    <div>
      <div class="breadcrumb">
        <div>
          <div>
            <ul>
              <li><a href="/us/en/solutions.html">Solutions</a></li>
              <li><a href="/us/en/solutions/cell-therapy.html">Cell Therapy</a></li>
              <li><a href="/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy.html">Autologous CAR-T Cell Therapy</a></li>
            </ul>
          </div>
        </div>
      </div>
      <hr>
      <div class="carousel">
        <div>
          <div>
            <h2>Autologous CAR-T Cell Therapy</h2>
            <p><a href="/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy/talk-to-expert.html">Talk to an Expert</a></p>
          </div>
          <div>
            <img src="https://author-dummy.adobeaemcloud.com/content/dam/danaher/solutions/autologous-car-t/car-t-hero.jpg" alt="autologous car-t">
          </div>
        </div>
      </div>
      <hr>
      <div class="page-jump-menu">
        <div>
          <div>:dam-Bookmark:</div>
          <div><a href="/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy.html">Overview</a></div>
        </div>
        <div>
          <div>:dam-Refresh:</div>
          <div><a href="/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy/process-steps.html">Process Steps</a></div>
        </div>
        <div>
          <div>:dam-Cube:</div>
          <div><a href="/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy/products.html">Products</a></div>
        </div>
        <div>
          <div>:dam-Chat:</div>
          <div><a href="/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy/talk-to-expert.html">Talk to an Expert</a></div>
        </div>
      </div>
      <hr>
      <h1>Autologous CAR-T Cell Therapy</h1>
      <h2><strong>WHY IT MATTERS</strong></h2>
      <h2>Unlocking the Healing Potential</h2>
      <p>Unlocking the healing potential of Autologous CAR-T cell therapy marks a significant leap forward for personalized medicine, offering a beacon of hope for patients diagnosed with certain types of cancer. By harnessing the patient's immune system to target and destroy cancer cells, CAR-T therapy represents a significant advancement in our ability to combat these malignancies. This approach's importance lies in its potential to improve patient survival rates and quality of life. It embodies cutting-edge biomedical innovation and patient-specific treatment protocols to lead to breakthroughs in curing diseases once deemed incurable. Through meticulous research development and application, unlocking the healing potential of Autologous CAR-T therapy is a crucial endeavor in the ongoing fight against cancer.</p>
      <h2>Select the Right Tools and Partner</h2>
      <p>Developing and manufacturing Autologous CAR-T cell therapies require high consistency in process and quality. Selecting the right tools and partnering with scientific experts is essential to achieve this.</p>
      <p>The Life Sciences companies of Danaher Corporation provide a vast array of solutions and technologies to aid in developing and producing Autologous CAR-T cell therapies. Our offerings cater from the discovery stage to clinical trials. We provide cutting-edge workflow automation, analytical solutions and enterprise-level data management solutions that can take your program to new heights. Our solutions are designed to empower you and help you achieve your goals quickly and efficiently.</p>
      <h2><strong>DANAHER IN THE NEWS</strong></h2>
      <h2>Danaher-University of Pennsylvania Beacon for Cell Therapy Innovation</h2>
      <p>Danaher Corporation has partnered with the University of Pennsylvania's Center for Cellular Immunotherapies, led by CAR-T pioneer Dr. Carl June. This partnership aims to develop advanced technologies that can improve the consistency of clinical outcomes for patients and overcome manufacturing bottlenecks in the delivery of next-generation engineered cell therapies like Autologous CAR-T. These therapies have immense potential to improve the treatment landscape for patients with limited options. However, the impact of CAR-T cell therapies on human health is limited by the inability to scale manufacturing processes in a cost- and time-effective way. This Beacon for Cell Therapy Innovation will focus on developing innovative product solutions that address bottlenecks affecting cell therapy manufacturing yield and quality.</p>
      <p><a href="https://investors.danaher.com/2023-03-07-Danaher-Partners-with-the-University-of-Pennsylvanias-Center-for-Cellular-Immunotherapies-to-Address-Manufacturing-Challenges-Impacting-the-Uptake-of-Cell-Therapies?utm_source=dhls_website">Learn More</a></p>
      <h2><strong>THE PROCESS</strong></h2>
      <h2>One lab, three paths to faster outcomes</h2>
      <div class="workflow-tabs">
        <div>
          <div>All</div>
          <div>/fragments/workflow_tabs/cell-therapy/car-t-cell-therapy/workflow-carousels/master</div>
        </div>
        <div>
          <div>Automation</div>
          <div>/fragments/workflow_tabs/cell-therapy/car-t-cell-therapy/workflow-carousels/automation</div>
        </div>
        <div>
          <div>Analytical</div>
          <div>/fragments/workflow_tabs/cell-therapy/car-t-cell-therapy/workflow-carousels/analytical</div>
        </div>
        <div>
          <div>Digital</div>
          <div>/fragments/workflow_tabs/cell-therapy/car-t-cell-therapy/workflow-carousels/digital</div>
        </div>
      </div>
      <hr>
      <h2><strong>PRODUCT SPOTLIGHT</strong></h2>
      <div class="columns itemscenter">
        <div>
          <div>
            <p><strong>Vi-CELL BLU Cell Viability Analyzer</strong></p>
            <h3>The faster Vi-CELL BLU cell analyzers automates the Trypan Blue Dye Exclusion method for cell viability analysis.</h3>
            <p>The Vi-CELL BLU expedites processing by now having the option to use a 24-position sample carousel or a 96 well plate for sample delivery.</p>
            <p><a href="/us/en/products/family/vi-cell-blu-cell-viability-analyzers.html">Learn More</a></p>
          </div>
          <div>
            <img src="https://s7d9.scene7.com/is/image/danaherstage/card-vi-cell-blu" alt="Danaher Corporation">
          </div>
        </div>
      </div>
      <p>
        <img src="https://s7d9.scene7.com/is/image/danaherstage/rule-line-black" alt="Danaher Corporation">
      </p>
      <div class="columns itemscenter">
        <div>
          <div>
            <p><strong>CytoFLEX Flow Cytometer</strong></p>
            <p>The CytoFLEX Flow Cytometer, the first introduction to the CytoFLEX Platform, provides the performance you need in an easy to use system allowing you to focus on the science, not the instrumentation.</p>
            <p>Its superior sensitivity and resolution throughout all configurations give it the edge over other cytometry systems four times its size. All instruments in the platform utilize CytExpert for CytoFLEX Acquisition and Analysis Software.</p>
            <p><a href="/us/en/products/family/cytoflex-flow-cytometer.html">Learn More</a></p>
          </div>
          <div>
            <img src="https://s7d9.scene7.com/is/image/danaherstage/card-cytoflex-lx" alt="Danaher Corporation">
          </div>
        </div>
      </div>
      <p>
        <img src="https://s7d9.scene7.com/is/image/danaherstage/rule-line-black" alt="Danaher Corporation">
      </p>
      <div class="columns itemscenter">
        <div>
          <div>
            <p><strong>Skyland PIMS</strong></p>
            <p>PIMS (Process Information Management System) is 21 CFR Part-11 compliant, cloud-native software that creates a contextualized data backbone of critical manufacturing process and quality data across products and batches.</p>
            <p><a href="/us/en/products/family/skyland-pims.html">Learn More</a></p>
          </div>
          <div>
            <img src="https://s7d9.scene7.com/is/image/danaherstage/card-skyland-pims" alt="Danaher Corporation">
          </div>
        </div>
      </div>
      <div class="carousel">
        <div>
          <div>
            <h2>Autologous CAR-T Cell Therapy</h2>
            <p><a href="/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy/talk-to-expert.html">Talk to an Expert</a></p>
          </div>
          <div>
            <img src="https://author-dummy.adobeaemcloud.com/content/dam/danaher/solutions/autologous-car-t/car-t-hero.jpg" alt="autologous car-t">
          </div>
        </div>
      </div>
      <div class="section-metadata">
        <div>
          <div>style</div>
          <div>container-two-col</div>
        </div>
      </div>
      <hr>
      <div class="metadata">
        <div>
          <div>Title</div>
          <div>Autologous CAR-T Cell Therapy: Development &#x26; Manufacturing | Danaher Life Sciences</div>
        </div>
        <div>
          <div>canonical</div>
          <div><a href="https://lifesciences.danaher.com/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy.html">https://lifesciences.danaher.com/us/en/solutions/cell-therapy/autologous-car-t-cell-therapy.html</a></div>
        </div>
        <div>
          <div>Description</div>
          <div>Explore analytical tools &#x26; digital solutions to accelerate autologous CAR-T cell therapy production. Improve patient outcomes through advanced technology.</div>
        </div>
        <div>
          <div>Image</div>
          <div>
            <img src="https://stage.lifesciences.danaher.com/content/dam/danaher/solutions/autologous-car-t/car-t-hero.jpg" alt="">
          </div>
        </div>
        <div>
          <div>creationDate</div>
          <div>Thu, 09 May 2024 14:39:20 GMT</div>
        </div>
        <div>
          <div>updateDate</div>
          <div>Wed, 26 Jun 2024 07:30:01 GMT</div>
        </div>
      </div>
    </div>
  </main>
  <footer></footer>
</body>
</html>